Kemnay Advisory Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Kemnay Advisory Services's ALNY Position: Q2 2026 in Review
Kemnay Advisory Services increased its Alnylam Pharmaceuticals (ALNY) stake by 5.7% in Q2 2026, buying an estimated $905 and bringing the position to 56 shares worth $16.9K. The position accounts for ﹤0.01% of the portfolio, ranked #833.
Kemnay Advisory Services first reported a position in ALNY in Q1 2020 and has held it in 4 quarters since. The position peaked at $1.34M in Q1 2020. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- Kemnay Advisory Services held 56 shares of Alnylam Pharmaceuticals worth $16.9K as of Q2 2026.
- Kemnay Advisory Services bought 3 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $905.
- Alnylam Pharmaceuticals made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #833 holding.
- Kemnay Advisory Services first reported a position in Alnylam Pharmaceuticals in Q1 2020 and has held it in 4 quarters since.
- Kemnay Advisory Services's Alnylam Pharmaceuticals position peaked at $1.34M in Q1 2020.
- 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.